{"document_type": "article", "byline": {"person": [{"role": "reported", "firstname": "Jeff", "organization": "", "rank": 1, "lastname": "SOMMER"}], "original": "By JEFF SOMMER"}, "news_desk": "SundayBusiness", "slideshow_credits": null, "abstract": "Jeff Sommer Strategies column asserts investors believe government will obstruct tax inversion merger of Allergan and Pfizer; public and politicians have been calling for end to such mergers. ", "multimedia": [{"type": "image", "url": "images/2016/03/13/business/13STRA/13STRA-thumbWide.jpg", "legacy": {"wide": "images/2016/03/13/business/13STRA/13STRA-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "width": 190, "subtype": "wide", "height": 126}, {"type": "image", "url": "images/2016/03/13/business/13STRA/13STRA-articleLarge.jpg", "legacy": {"xlarge": "images/2016/03/13/business/13STRA/13STRA-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "375"}, "width": 600, "subtype": "xlarge", "height": 375}, {"type": "image", "url": "images/2016/03/13/business/13STRA/13STRA-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/03/13/business/13STRA/13STRA-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "width": 75, "subtype": "thumbnail", "height": 75}], "headline": {"kicker": "Strategies", "content_kicker": "Strategies", "print_headline": "Pfizer\u2019s Eager to Go, but the Market Has Doubts", "main": "Pfizer\u2019s Eager to Go, but the Market Has Doubts"}, "print_page": "7", "keywords": [{"value": "Allergan Inc", "is_major": "Y", "rank": "1", "name": "organizations"}, {"value": "Pfizer Inc", "is_major": "Y", "rank": "2", "name": "organizations"}, {"value": "Corporate Taxes", "is_major": "Y", "rank": "3", "name": "subject"}, {"value": "Taxation", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "Mergers, Acquisitions and Divestitures", "is_major": "N", "rank": "5", "name": "subject"}, {"value": "Treasury Department", "is_major": "N", "rank": "6", "name": "organizations"}, {"value": "Tax Shelters", "is_major": "N", "rank": "7", "name": "subject"}], "snippet": "A spread in share prices suggests that the drug maker\u2019s tax inversion deal with Allergan may not yet be in the bag.", "source": "The New York Times", "lead_paragraph": "A spread in share prices suggests that the drug maker\u2019s tax inversion deal with Allergan may not yet be in the bag.", "word_count": "1217", "pub_date": "2016-03-13T00:00:00Z", "subsection_name": null, "blog": [], "type_of_material": "News", "section_name": "Your Money", "web_url": "http://www.nytimes.com/2016/03/13/your-money/pfizers-eager-to-go-but-the-market-has-doubts.html", "_id": "56e4634038f0d83a21f5bde6"}